Publication:
GLP-1 and the renin-angiotensin-aldosterone system.

dc.contributor.authorJiménez, David León
dc.contributor.authorBabkowski, Miguel Camafort
dc.contributor.authorMiramontes González, José Pablo
dc.date.accessioned2023-01-25T13:32:01Z
dc.date.available2023-01-25T13:32:01Z
dc.date.issued2019-03-07
dc.identifier.doi10.1016/S2213-8587(19)30065-8
dc.identifier.essn2213-8595
dc.identifier.pmid30853620
dc.identifier.unpaywallURLhttp://www.thelancet.com/article/S2213858719300658/pdf
dc.identifier.urihttp://hdl.handle.net/10668/13682
dc.issue.number5
dc.journal.titleThe lancet. Diabetes & endocrinology
dc.journal.titleabbreviationLancet Diabetes Endocrinol
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number337
dc.pubmedtypeLetter
dc.pubmedtypeComment
dc.rights.accessRightsopen access
dc.subject.meshAngiotensin-Converting Enzyme Inhibitors
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshGlucagon-Like Peptide 1
dc.subject.meshHumans
dc.subject.meshRenin
dc.subject.meshRenin-Angiotensin System
dc.titleGLP-1 and the renin-angiotensin-aldosterone system.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number7
dspace.entity.typePublication

Files